Susann Busch

Biochemistry, Genetics and Molecular Biology · Life Sciences

12h-index866citations50works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

TGF-β signaling in diseases(30), Estrogen and related hormone effects(10), Cancer Cells and Metastasis(8), Reproductive System and Pregnancy(8), Genetic factors in colorectal cancer(7)

Publications50 total

Supplementary Figure S1 from Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance
2023Open Access
Supplementary Table S3 from Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance
2023Open Access
Data from Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance
2023Open Access
Supplementary Figure S4 from Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance
2023Open Access
Supplementary Figure S4 from Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance
2023Open Access
Supplementary Figure S1 from Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance
2023Open Access
Supplementary Table S4 from Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance
2023Open Access
Supplementary Table S2 from Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance
2023Open Access
Supplementary Figure S3 from Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance
2023Open Access
Supplementary Figure S6 from Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance
2023Open Access
Supplementary Figure S2 from Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance
2023Open Access
Supplementary Table S1 from Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance
2023Open Access
Data from Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance
2023Open Access
Supplementary Figure S2 from Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance
2023Open Access
Supplementary Table S2 from Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance
2023Open Access
Supplementary Figure S3 from Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance
2023Open Access
Supplementary Figure S7 from Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance
2023Open Access
Supplementary Figure S5 from Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance
2023Open Access
Supplementary Figure S8 from Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance
2023Open Access
Supplementary Table S4 from Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Göran Landberg(34), Olle Stål(28), Andrew H. Sims(27), Mårten Fernö(27), Udo R. Markert(12), E Schleußner(8), Tobias G. Poehlmann(6), Justine S. Fitzgerald(5), T.G. Poehlmann(5), Julia Roediger(4), Rebecca Lamb(3), Astrid Enkelmann(3), Pernilla Gregersson(2), Lisa Rydén(2), Karin Jirström(2), Daniel Andersson(2), Anders Ståhlberg(2), Andreas Schaumann(2), Anne Braunschweig(2), Gabriela Gutiérrez(2)